{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T17:30:00Z","timestamp":1747243800586,"version":"3.37.3"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2022R1A2C2003528"],"award-info":[{"award-number":["2022R1A2C2003528"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","ijoms.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ijom.2024.05.001","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T05:33:27Z","timestamp":1716356007000},"page":"873-880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oral lesions associated with imatinib mesylate therapy: five new cases and a literature review"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9900-2329","authenticated-orcid":false,"given":"Y.-J.","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9960-9892","authenticated-orcid":false,"given":"H.-S.","family":"Kho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijom.2024.05.001_bib1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/ijd.13931","article-title":"Imatinib-induced diffuse hyperpigmentation of the oral mucosa, the skin, and the nails in a patient affected by chronic myeloid leukemia: report of a case and review of the literature","volume":"57","author":"Di Tullio","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ijom.2024.05.001_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00204-011-0729-7","article-title":"The safety profile of imatinib in CML and GIST: long-term considerations","volume":"86","author":"Thanopoulou","year":"2012","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.ijom.2024.05.001_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/B978-0-12-800173-8.00006-4","article-title":"Imatinib mesylate","volume":"39","author":"Al-Hadiya","year":"2014","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"10.1016\/j.ijom.2024.05.001_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40902-017-0136-y","article-title":"Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib","volume":"39","author":"Bombeccari","year":"2017","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"10.1016\/j.ijom.2024.05.001_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1902\/cap.2016.160050","article-title":"Oral effects and early implant survival results after imatinib discontinuation therapy for chronic myelogenous leukemia: a case report","volume":"7","author":"Dixon","year":"2017","journal-title":"Clin Adv Periodont"},{"key":"10.1016\/j.ijom.2024.05.001_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.oooo.2020.10.015","article-title":"The blue palate\u2014a case series of imatinib-related oral pigmentation and literature review","volume":"131","author":"Donnell","year":"2021","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.ijom.2024.05.001_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3109\/10428194.2012.702904","article-title":"Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT","volume":"54","author":"Khoo","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijom.2024.05.001_bib8","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ajoms.2022.05.008","article-title":"Imatinib-induced hyperpigmentation of the hard palate in a Japanese patient with chronic myeloid leukemia: a case report","volume":"34","author":"Kono","year":"2022","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"10.1016\/j.ijom.2024.05.001_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12105-011-0325-4","article-title":"Mucosal pigmentation caused by imatinib: report of three cases","volume":"6","author":"Li","year":"2012","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.ijom.2024.05.001_bib10","first-page":"95","article-title":"A large gray-blue macule on the hard palate as an adverse effect of imatinib","volume":"116","author":"Lueken","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.ijom.2024.05.001_bib11","article-title":"Mucosal pigmentation of the hard palate in a patient taking imatinib","volume":"2015","author":"Lyne","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ijom.2024.05.001_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jds.2019.02.005","article-title":"Imatinib-related hyperpigmentation of oral mucosa: case report and literature review","volume":"14","author":"Mascitti","year":"2019","journal-title":"J Dent Sci"},{"key":"10.1016\/j.ijom.2024.05.001_bib13","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/j.tripleo.2010.11.006","article-title":"Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three cases","volume":"111","author":"Mattsson","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ijom.2024.05.001_bib14","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/j.jcms.2011.07.010","article-title":"Imatinib-associated hyperpigmentation of the palate in post-HSCT patient","volume":"40","author":"Resende","year":"2012","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.ijom.2024.05.001_bib15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ajh.23589","article-title":"Imatinib-associated melanosis of the palate","volume":"89","author":"Roeker","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ijom.2024.05.001_bib16","article-title":"A rare case of melanosis of the hard palate mucosa in a patient with chronic myeloid leukemia","volume":"2015","author":"Romeo","year":"2015","journal-title":"Case Rep Dent"},{"key":"10.1016\/j.ijom.2024.05.001_bib17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5021\/ad.2014.26.4.532","article-title":"Imatinib mesylate-induced hyperpigmentation of the nose and palate","volume":"26","author":"Song","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.ijom.2024.05.001_bib18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2230.2011.04196.x","article-title":"Oral mucosal hyperpigmentation and horizontal melanonychia caused by imatinib","volume":"37","author":"Steele","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ijom.2024.05.001_bib19","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.oooo.2017.10.006","article-title":"Drug-associated hyperpigmentation of the oral mucosa: report of four cases","volume":"125","author":"Tosios","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.ijom.2024.05.001_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D3498194BX","article-title":"Oral melanosis after tyrosine kinase inhibition with imatinib for chronic myelogenous leukemia: report of a case and review of the literature","volume":"17","author":"Wong","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ijom.2024.05.001_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0378-6323.125505","article-title":"Imatinib mesylate-induced severe lichenoid rash","volume":"80","author":"Arshdeep","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.ijom.2024.05.001_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00520-008-0536-8","article-title":"Skin and oral lesions associated to imatinib mesylate therapy","volume":"17","author":"Basso","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijom.2024.05.001_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/2229-516X.149253","article-title":"Lichenoid drug eruption due to imatinib mesylate","volume":"5","author":"Bhatia","year":"2015","journal-title":"Int J Appl Basic Med Res"},{"key":"10.1016\/j.ijom.2024.05.001_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0781.2011.00621.x","article-title":"Photoinduced dermatitis and oral lichenoid reaction in a chronic myeloid leukemia patient treated with imatinib mesylate","volume":"28","author":"Brazzelli","year":"2012","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.ijom.2024.05.001_bib25","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1365-2133.2006.07276.x","article-title":"Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect","volume":"154","author":"Dalmau","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijom.2024.05.001_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/09546630410015556","article-title":"Oral lichenoid eruption secondary to imatinib (Glivec)","volume":"15","author":"Ena","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ijom.2024.05.001_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1684\/ejd.2010.0818","article-title":"Oral lichenoid eruption associated with imatinib treatment","volume":"20","author":"G\u00f3mez Fern\u00e1ndez","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ijom.2024.05.001_bib28","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1111\/ijd.12174","article-title":"Lichenoid drug eruption with hyperpigmentation caused by imatinib mesylate","volume":"53","author":"Kagimoto","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ijom.2024.05.001_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000063899","article-title":"Oral lichenoid reaction to imatinib (STI 571, Gleevec)","volume":"205","author":"Lim","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.ijom.2024.05.001_bib30","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1365-4632.2006.03171.x","article-title":"Oral and cutaneous lichenoid reaction secondary to imatinib: report of two cases","volume":"45","author":"Pascual","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ijom.2024.05.001_bib31","first-page":"189","article-title":"Imatinib mesylate-induced lichenoid drug eruption","volume":"99","author":"Penn","year":"2017","journal-title":"Cutis"},{"key":"10.1016\/j.ijom.2024.05.001_bib32","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1111\/j.1365-2230.2009.03266.x","article-title":"Lichenoid drug eruption related to imatinib: report of a new case and review of the literature","volume":"34","author":"Sendagorta","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ijom.2024.05.001_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5070\/D319T833JH","article-title":"Oral and cutaneous lichenoid reaction with nail changes secondary to imatinib: report of a case and literature review","volume":"14","author":"Wahiduzzaman","year":"2008","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ijom.2024.05.001_bib34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5021\/ad.2015.27.2.228","article-title":"Oral and cutaneous lichenoid eruption with nail changes due to imatinib treatment in a Chinese patient with chronic myeloid leukemia","volume":"27","author":"Zhang","year":"2015","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.ijom.2024.05.001_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.oooo.2017.10.010","article-title":"Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. A report of 7 cases from the Copenhagen Cohort","volume":"125","author":"Abel Mahedi Mohamed","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.ijom.2024.05.001_bib36","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.oooo.2020.10.005","article-title":"Osteonecrosis of the jaw associated with imatinib therapy in myeloproliferative neoplasm: a rare case report","volume":"131","author":"Gupta","year":"2021","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.ijom.2024.05.001_bib37","first-page":"29","article-title":"Osteonecrosis of the jaw in a patient with chronic myelogenous leukemia receiving imatinib\u2014a case report with clinical implications","volume":"4","author":"Nicolatou-Galitis","year":"2013","journal-title":"Forum Clin Oncol"},{"key":"10.1016\/j.ijom.2024.05.001_bib38","article-title":"Medication-related osteonecrosis of the jaw spontaneously occurred in a patient with chronic myelogenous leukemia only by imatinib: a report of a rare case","volume":"2021","author":"Okubo-Sato","year":"2021","journal-title":"Case Rep Dent"},{"key":"10.1016\/j.ijom.2024.05.001_bib39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5125\/jkaoms.2017.43.2.120","article-title":"A rare case of osteonecrosis of the jaw related to imatinib","volume":"43","author":"Viviano","year":"2017","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2024.05.001_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12105-018-0980-9","article-title":"Black and brown: non-neoplastic pigmentation of the oral mucosa","volume":"13","author":"Rosebush","year":"2019","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.ijom.2024.05.001_bib41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tripleo.2008.07.022","article-title":"Pigmentation of the hard palate","volume":"107","author":"Lerman","year":"2009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ijom.2024.05.001_bib42","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.tripleo.2007.07.047","article-title":"Pigmented lesions of the oral mucosa and perioral tissues: a flow-chart for the diagnosis and some recommendations for the management","volume":"105","author":"Meleti","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ijom.2024.05.001_bib43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/ors.12194","article-title":"Intraoral hyperpigmentation due to imatinib mesylate. A review of the literature","volume":"9","author":"Pancholi","year":"2016","journal-title":"Oral Surg"},{"key":"10.1016\/j.ijom.2024.05.001_bib44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-3083.2008.02706.x","article-title":"Imatinib-associated hyperpigmentation, a side effect that should be recognized","volume":"23","author":"Mcpherson","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijom.2024.05.001_bib45","first-page":"S25.e1","article-title":"Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations","volume":"103 Suppl","author":"Al-Hashimi","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ijom.2024.05.001_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/0973-029X.84474","article-title":"Oral lichen planus: an update on pathogenesis and treatment","volume":"15","author":"Lavanya","year":"2011","journal-title":"J Oral Maxillofac Pathol"},{"key":"10.1016\/j.ijom.2024.05.001_bib47","first-page":"e167","article-title":"Drug-induced burning mouth syndrome: a new etiological diagnosis","volume":"13","author":"Salort-Llorca","year":"2008","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.ijom.2024.05.001_bib48","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/odi.13116","article-title":"Is there an association between drugs and burning mouth syndrome? A case\u2013control study","volume":"25","author":"Azzi","year":"2019","journal-title":"Oral Dis"},{"key":"10.1016\/j.ijom.2024.05.001_bib49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00238-015-1112-3","article-title":"Sunitinib related osteonecrosis of the jaw (SURONJ): a rare occurrence?","volume":"39","author":"Melloni","year":"2016","journal-title":"Eur J Plast Surg"},{"key":"10.1016\/j.ijom.2024.05.001_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10006-020-00913-z","article-title":"Osteonecrosis of the jaws associated with protein kinase inhibitors: a systematic review","volume":"25","author":"Mian","year":"2021","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2024.05.001_bib51","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00520-017-3903-5","article-title":"Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors","volume":"26","author":"van Cann","year":"2018","journal-title":"Support Care Cancer"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502724001462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502724001462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T03:34:52Z","timestamp":1724470492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0901502724001462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0901502724001462"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2024.05.001","relation":{},"ISSN":["0901-5027"],"issn-type":[{"type":"print","value":"0901-5027"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral lesions associated with imatinib mesylate therapy: five new cases and a literature review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijom.2024.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}